載入...
Safinamide: an add-on treatment for managing Parkinson’s disease
Heterogeneous expression of neurotransmitter deficits results from onset and progression of Parkinson’s disease. Intervals, characterized by reappearance of motor and associated certain nonmotor symptoms, determine the end of good tolerability and efficacy of oral levodopa therapy. These “OFF” state...
Na minha lista:
| 發表在: | Clin Pharmacol |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5896660/ https://ncbi.nlm.nih.gov/pubmed/29670409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S137740 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|